Oxaliplatin; Capecitabine

DRUG2 trials

Sponsors

Hebei Medical University

Conditions

Gastric CancerGastroesophageal Junction Adenocarcinoma

Phase 2

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

CompletedNCT01516944

Hebei Medical UniversityGastric Cancer

Start: 2012-02-29End: 2018-12-31Updated: 2020-02-13

Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction

CompletedNCT01962246

Hebei Medical UniversityGastroesophageal Junction Adenocarcinoma

Start: 2012-02-29End: 2021-08-31Updated: 2022-02-21

Related Papers

A deep learning–based digital biopsy for predicting early recurrence in gastric cancer

Nature Communications2026-04-15

Radiomics-based ensemble model predicts postoperative recurrence of gastric cancer.

2025-11-25

Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective study.

2024-08-1510 citations

Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction

Frontiers in Oncology2021-11-1111 citations

[Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].

PubMed2021-02-258 citations

The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial

Cancer Medicine2020-06-2435 citations

[Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].

PubMed2020-02-254 citations

Perioperative chemotherapy vs. adjuvant chemotherapy for potentially resectable gastric cancer: A randomized and multicenter phase III study in locally advanced gastric cancer with D2 dissection.

Journal of Clinical Oncology2015-05-201 citations